Le Lézard
Classified in: Health
Subject: PER

Getinge appoints Patricia Fitch as President North America Region


GOTHENBURG, Sweden, Jan. 17, 2022 /PRNewswire/ -- Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge.

Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership roles in sales, marketing and operations with multi-national corporations such as Johnson & Johnson, Abiomed, St. Jude Medical and 3M.

Eric Honroth has been appointed President Life Science and member of the Getinge Executive team. Eric joined Getinge 2018 and will succeed Harald Castler, who after a long and successful career in Getinge has decided to retire.

All changes are effective as of April 1, 2022.

Media contact
Anna Appelqvist, VP Corporate Communications
Phone: +46 734 244 527
Email: [email protected]

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/getinge/r/getinge-appoints-patricia-fitch-as-president-north-america-region,c3487396

The following files are available for download:

https://mb.cision.com/Main/942/3487396/1521281.pdf

Getinge appoints Patricia Fitch as President North America Region

https://news.cision.com/getinge/i/patricia-fitch,c3000666

Patricia Fitch

SOURCE Cision AB


These press releases may also interest you

at 08:15
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it will be attending the LSX World Congress (29-30 April) and presenting at Bio?quity Europe (12-14 May). The...

at 08:15
Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations highlighting positive efficacy and safety...

at 08:15
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms....

at 08:10
Edgewise Therapeutics, Inc. , a leading muscle disease biopharmaceutical company, today announced that the Company will present data on EDG-7500 at the American College of Cardiology's Annual Scientific Session (ACC.24). EDG-7500 is a first-in-class...

at 08:05
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed...

at 08:05
Bio-K Plus, a Kerry Company, pioneer in the probiotic sector, is pleased to announce the launch of its new functional drinkable probiotic, the Extra Stress Support with Sensoril®....



News published on and distributed by: